LIBRITABS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Libritabs, and what generic alternatives are available?
Libritabs is a drug marketed by Valeant Pharm Intl and is included in three NDAs.
The generic ingredient in LIBRITABS is chlordiazepoxide. There are nine drug master file entries for this compound. Additional details are available on the chlordiazepoxide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIBRITABS?
- What are the global sales for LIBRITABS?
- What is Average Wholesale Price for LIBRITABS?
Summary for LIBRITABS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Patent Applications: | 7,688 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LIBRITABS at DailyMed |
![LIBRITABS drug patent expirations Drug patent expirations by year for LIBRITABS](/p/graph/s/t/LIBRITABS-patent-expirations.png)
US Patents and Regulatory Information for LIBRITABS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085482-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085481-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Pharm Intl | LIBRITABS | chlordiazepoxide | TABLET;ORAL | 085488-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |